Recent news highlights include steady or rising funds from operations, net income reports for Q3 2026, dividend announcements, and stock price movements related to earnings releases.

• Universal Health Realty reported net income of $4.9 million for Q3 2026, with funds from operations rising year-over-year [N2].
• The company’s stock showed gains following Q3 2026 earnings and FFO improvements [N1].
• A cash dividend was announced in September 2026 [N3].
• Post Q2 2026 earnings, the stock gained as FFO improved [N4].
• Following Q1 2026 earnings, the stock slipped despite rising FFO [N5].
• After Q4 2025 earnings, the stock gained despite a revenue decline [N6].
• Steady Q3 2025 earnings and dividend announcements supported stock gains [N7].
• Stock declined after mixed Q2 2025 earnings results [N8].

The company benefits from a diversified portfolio of healthcare-related real estate assets with long-term leases to established operators, including a significant portion leased to Universal Health Services, Inc. Recent quarters show rising funds from operations and steady dividend payments, indicating operational stability. The ongoing development of new medical office buildings demonstrates active portfolio management and growth in rentable assets. Geographic diversification across multiple states reduces concentration risk. The company’s focus on healthcare properties aligns with a sector that typically has resilient demand due to the essential nature of healthcare services [N1][N2][N3][N4].

The company faces concentration risk due to reliance on Universal Health Services, Inc. for approximately 40% of revenues, which could impact rental income if leases are not renewed or if tenants exercise purchase options on properties. Rising interest rates have increased borrowing costs, potentially reducing net income and limiting capital access. Legislative changes affecting Medicaid and healthcare funding may reduce tenant revenues and increase uncompensated care, negatively impacting the company’s results. Inflationary pressures and staffing shortages experienced by tenants could affect their financial stability and ability to meet lease obligations. Vacancies and properties under development carry execution and market risks [S1][S2].

Universal Health Realty Income Trust's moat derives from its specialized focus on healthcare real estate, a niche requiring expertise in property types such as hospitals, behavioral health facilities, and medical office buildings. Its long-term leases with established healthcare operators, particularly Universal Health Services, Inc., provide stable rental income. The geographic diversification across twenty-one states and a portfolio mix of owned and partially owned properties contribute to risk mitigation. The company's ability to develop and lease new medical office buildings also supports its competitive position. However, reliance on a major tenant and regulatory risks in healthcare funding present challenges to the moat [S1].

• Tenant Concentration Risk: Approximately 40% of revenues come from subsidiaries of Universal Health Services, Inc. Non-renewal or purchase of leased properties by these tenants could materially reduce rental income.
• Interest Rate Risk: Increased interest rates have raised borrowing costs, reducing net income and cash flow, and may affect the company’s ability to finance new investments on favorable terms.
• Regulatory and Legislative Risk: Changes in healthcare legislation, including Medicaid eligibility and funding limits, may reduce tenant revenues and increase uncompensated care, adversely impacting the company’s financial results.
• Inflation and Operational Risks for Tenants: Inflationary pressures and staffing shortages experienced by tenants can affect their operating results and ability to pay rent, potentially impacting the company’s cash flows.

• Universal Health Realty Income Trust is a real estate investment trust (REIT) focused on healthcare and human service related facilities, including acute care hospitals, behavioral health care hospitals, specialty facilities, free-standing emergency departments, childcare centers, and medical/office buildings [S1].
• As of February 25, 2026, the company owns or has commitments in seventy-seven real estate investments across twenty-one states, including six hospital facilities (three acute care and three behavioral health), four free-standing emergency departments, sixty-one medical/office buildings, four preschool and childcare centers, one specialty facility (vacant), and vacant land [S1].
• The company leases many properties to subsidiaries of Universal Health Services, Inc. (UHS), which accounted for approximately 40% of consolidated revenues in 2025, 2024, and 2023 [S1].
• The portfolio includes properties leased to unaffiliated third parties and non-controlling interests in LLCs/LPs with third-party tenants [S1].
• The company’s principal executive offices are located in King of Prussia, Pennsylvania [S1].
• As of September 30, 2026, the company reported cash and cash equivalents of $6.471 million and revenues of $25.346 million for the third quarter [S2].
• Net income for the third quarter of 2026 was $4.929 million, with basic and diluted earnings per share of $0.36 and $0.35 respectively [S2].
• The company has a history of quarterly earnings and funds from operations (FFO) fluctuations, with recent quarters showing rising FFO year-over-year and steady dividends [N1][N2][N3][N4][N5][N6][N7][N8].
• The company announced a cash dividend in September 2026 [N3].
• The company’s portfolio includes properties under development, such as the Palm Beach Gardens Medical Plaza I, an 80,000 square foot medical office building with construction started in February 2026 [S1].
• The company faces risks related to dependence on UHS as a major tenant, interest rate fluctuations affecting borrowing costs, legislative changes impacting Medicaid and healthcare funding, and inflationary pressures on tenants’ operating costs [S1].
• There have been no material changes in risk factors as of the latest quarterly filing in November 2026 [S2].